On July 9th, 2024, SpOvum Technologies had the distinct honor of hosting Prof. Stephen Senturia, a distinguished Professor Emeritus of Electrical Engineering from the Massachusetts Institute of Technology. Prof. Senturia, known for his groundbreaking work in the field of electrical engineering and his significant contributions to academia and industry, brought a wealth of knowledge and experience to our discussions.
A Day of Insightful Exchanges and Exploration
During his visit, Prof. Senturia engaged in meaningful conversations with our directors, Dr. Ramnath Babu and Dr. Santosh Bhargav, along with the SpOvum team. The discussions covered various aspects of our ongoing projects and future innovations in the field of assisted reproductive technology (ART). Prof. Senturia’s insights, drawn from his extensive career and academic prowess, provided us with new perspectives and ideas to further our mission of advancing fertility treatments.
Lab and Office Tour
Prof. Senturia’s tour of our state-of-the-art labs and office facilities highlighted the cutting-edge technologies and methodologies we employ at SpOvum. He was particularly interested in our flagship product, RoboICSI®, and our innovative A.R.T. Dashboard, both of which have been designed to enhance the efficiency and effectiveness of fertility treatments.
Keynote at ISSS 2024 Conference
Adding to the significance of his visit, Prof. Senturia was the keynote speaker at the ISSS 2024 conference held at the Indian Institute of Science (IISc). His keynote address underscored his commitment to advancing scientific knowledge and education, inspiring many in the academic and research communities.
Looking Forward
Prof. Senturia’s visit was not only a moment of pride for SpOvum Technologies but also an opportunity to reflect on our journey and the path ahead. His encouragement and feedback have strengthened our resolve to push the boundaries of innovation in ART.
At SpOvum, we remain dedicated to transforming the landscape of fertility treatments through our relentless pursuit of excellence and innovation. We look forward to future collaborations and exchanges that continue to drive our mission forward.
We thank Prof. Stephen Senturia for his visit and the invaluable contributions he made during his time with us. His visit has undoubtedly left a lasting impact on our team and our work.
In the bustling city of Bengaluru, tucked away in the vibrant neighborhood of Nagarbhavi, lies a beacon of hope for countless individuals longing to embrace parenthood – the Miracle IVF center.
At the heart of Miracle IVF lies cutting-edge technology coupled with a human-centric approach. The journey begins with personalized consultations, where patients are embraced with empathy and understanding. From there, a meticulously tailored treatment plan unfolds, incorporating the latest advancements in assisted reproductive techniques.
Through procedures like Intrauterine Insemination (IUI), Intracytoplasmic Sperm Injection (ICSI), and In Vitro Fertilisation (IVF), Miracle IVF harnesses the power of science to overcome infertility barriers. Every step of the way, patients are guided with unwavering support, ensuring they feel empowered and informed at every turn.
Currently led by the President of Bangalore Society of Obstetrics and Gynecology-Dr Rekha Rajendrakumar, makes it a place with the best clinical practice with a strong academic background
To multiply its legacy, Miracle IVF is now collaborating with SpOvum Technologies Pvt Ltd for embryology services. It is a Bengaluru-based fertility-tech company founded by the alumni of IISc, Dr Santosh Bhargav and Dr Ramnath Babu. It provides end-to-end embryology solutions and support currently operating with many hospitals in India.
Having the best people with a strong academic background makes this alliance the best place to deliver excellent results when it comes to fertility treatments.
SpOvum Technologies recently participated in the German Delegation Program at IISc on November 21, 2023. This event was a pivotal moment for SpOvum to introduce its Embryo Monitoring System (EMS) to key stakeholders, including representatives from the German Ministry and experts in reproductive medicine. The program aimed to explore potential collaborations and market opportunities in Germany.
The German Delegation Program provided an ideal platform to showcase EMS, highlighting its innovative features and benefits in enhancing the success rates of ART procedures. Engaging discussions with the German Ministry opened avenues for future collaborations and partnerships, emphasizing mutual interests in advancing reproductive healthcare technologies.
Participating in this program was strategic for SpOvum’s global expansion, facilitating networking opportunities and insights into the German market. The event reaffirmed SpOvum’s commitment to innovation and laid the groundwork for entering the German market effectively.
Overall, the German Delegation Program was instrumental in positioning SpOvum for success in Germany and beyond. It reinforced SpOvum’s leadership in assisted reproduction and set the stage for future growth and collaboration in the field.
SpOvum, a distinguished ISO 13485-certified company, has signed a monumental services agreement with EUMED Hospital Palakkad. This collaboration aims to revolutionize embryology services and offer comprehensive solutions to the medical community and patients alike.
EUMED Hospital Palakkad, known for its commitment to excellence and advanced healthcare services, has taken a significant leap forward by entrusting SpOvum with the responsibility of managing embryology operations. This includes the procurement and management of consumables, maintaining meticulous records, handling data management, and ensuring the seamless maintenance of devices.
ISO 13485 Certification: A Seal of Quality
SpOvum’s ISO 13485 certification is a testament to its unwavering dedication to quality and safety standards in the medical industry. ISO 13485 is an internationally recognized standard that sets forth strict requirements for the design, development, production, and distribution of medical devices. By partnering with an ISO 13485-certified company, EUMED Hospital Palakkad has taken a significant step towards enhancing the quality and reliability of its embryology services.
Comprehensive Embryology Services
The association of SpOvum and EUMED Hospital Palakkad is poised to provide a range of services that will greatly benefit the hospital and its patients:
Consumable Management: SpOvum will ensure a steady supply of high-quality consumables, such as culture media, labware, and equipment, to support the hospital’s embryology operations. This will lead to more consistent and reliable results in IVF and other assisted reproductive technologies.
Record Keeping: Maintaining accurate and organized records is essential in embryology. SpOvum’s expertise in this area will not only help in documenting patient information but also in ensuring regulatory compliance and improving the overall quality of care.
Data Management: Effective data management is crucial in the healthcare sector. SpOvum will implement state-of-the-art data management systems to securely handle patient data and laboratory information, maintaining patient privacy and ensuring the integrity of records.
Device Maintenance: The proper functioning of medical devices is critical in embryology procedures. SpOvum will take care of device maintenance, ensuring that all equipment operates at peak efficiency and reliability, reducing the risk of errors and complications.
This partnership is set to not only streamline the hospital’s embryology operations but also enhance the patient experience. Patients seeking fertility treatments at EUMED Hospital Palakkad can now benefit from the combined expertise of the hospital’s medical staff and SpOvum’s commitment to quality and precision.
In conclusion, the collaboration between SpOvum and EUMED Hospital Palakkad signifies a positive shift in healthcare, exemplifying the importance of quality, data management, and the need for cutting-edge technology in modern medical practices. This partnership promises to deliver higher success rates in fertility treatments, ensuring the well-being of patients and bringing hope to many families.
“Srishti Advanced Fertility and Endoscopy in Hubli is one of the leading facilities in women’s health. We as a company specialize in offering technical support for delivering comprehensive IVF services, ensuring exceptional care through sensor-based quality maintenance. If you are expecting to be a healthy mother or simply having issues relating to women’s health, we strongly recommend you to visit us for the best possible results.”
ಎರಡು ದಶಕಗಳಿಂದ ಸೃಷ್ಟಿ ಅಡ್ವಾನ್ಸ್ಡ್ ಫರ್ಟಿಲಿಟಿ ಮತ್ತು ಎಂಡೊಸ್ಕೋಪಿ ಬಂಜೆತನದ ಸಮಸ್ಯೆ ಇರುವ ಮಹಿಳೆಯರಿಗೆ ಮತ್ತು ಅವರ ಸಮಸ್ಯೆಗಳಿಗೆ ಉತ್ತಮ ಗುಣಮಟ್ಟದ ಆರೈಕೆ ಮತ್ತು ಚಿಕಿತ್ಸೆ ಎಲ್ಲವೂ ಕೈಗೆಟುಕುವ ದರದಲ್ಲಿ ನೀಡುವಲ್ಲಿ ಅವಿರತವಾಗಿ ನಿರತವಾಗಿದೆ. ಜೊತೆಗೆ ಸ್ಪೋವಮ್ ಟೆಕ್ನಾಲಜಿಸ್ ಸಮಗ್ರ ಐವಿಎಫ್ ಸೇವೆಗಳನ್ನು ಒದಗಿಸಲು ತಾಂತ್ರಿಕ ಬೆಂಬಲವನ್ನು ನೀಡುವಲ್ಲಿ ಪರಿಣತಿ ಹೊಂದಿರುವ ಕಂಪನಿಯಾಗಿದೆ. ಸೆನ್ಸಾರ್ ಆಧರಿತ ಉತ್ತಮ ಗುಣಮಟ್ಟದ ಮೂಲಕ ಅತ್ಯಮೂಲ್ಯ ಕಾಳಜಿಯನ್ನು ಖಾತ್ರಿಪಡಿಸುತ್ತಿದೆ.
A lady, married for 10 years never had a period in her life. With our help, her periods resumed and, she conceived successfully on the second IVF cycle
An article in a Kannada newspaper was published on the importance of Mane Hospital’s LifeNu IVF center at Bagalkote City in northern Karnataka. The state-of-the-art technology enabled by SpOvum Technologies is much appreciated.
Here is the English Translation of the article
In 2018, Mane Multispecialty Hospital started an IVF center called LifeNu IVF center with all facilities for the first time in Bagalkot district. This is saving the time and money of many women who were going to different places for infertility treatment. From 2022 at Mane Hospital, in collaboration with SpOvum Technologies Company, the hospital has implemented quality maintenance technology at all stages of treatment through sensors. All treatments for infertility are available, including state-of-the-art ICSI technology treatment at affordable rates. Due to this, not only people who were going to different cities for IVF treatment from many parts of North Karnataka like Koppala, Gadag, Vijayapur, and Belgaum are getting treatment at Dr. Mane Hospital’s LifeNu IVF center in Bagalkot, but also Dr. Vaishali has examples of couples from Bengaluru who came for the treatment and got children.
Understanding the onset of embryonic arrest by studying the morphology of the embryos at different stages of their development is a relatively well-understood subject. The qualitative nature of the study makes it difficult to determine and quantify the causes behind the arrest. For successful embryonic development, it is essential to know, non-destructively, and the developmental viability of the embryos at a particular stage.
We investigate the bulk stiffness and recovery time as the viability quantifiers for grading or classifying embryos at the two-cell stage or after the formation of the first cleavage. A simple cantilever beam-based experimental procedure is established to investigate two-cell mouse embryos in two distinct orientations.
Bulk stiffness measurement varies with the embryo’s orientation and deformation. A good quality two-cell embryo shows a significant decrease in stiffness ratio with the deformation. Also, the embryo’s recovery time after releasing deformation may indicate a quality-dependent correlation.
Our study concludes that the bulk stiffness measurements in the two principal orientations, their ratio, and recovery time correlate with the underlying morphology of two-cell stage mouse embryos.